InvestorsHub Logo

biopharm

07/25/17 5:08 PM

#305485 RE: biopharm #300403

"Interesting post Cheynew for back in Feb 2014 there

More interesting is Steve Demattos failed to update his LinkedIn profile for the longest time and only a few weeks after that last post...Steve was settling in over at Xencor where he BEGAN employment in March of 2014

Hmmm... Sort of matches the rise of PPHM to $3 and with John Stafford sitting on the BOD at Xencor during these times he certainly knew Steve Demattos ....

The question is what else did he know to all of a sudden acquire about 30 Million shares of PPHM recently

Did John Stafford have to resign Xencor in order to invest big time into Peregrine? I say yes "

One more disclosure we need John Stafford(ex Xenecor..) to explain and with Xenecor partnership with Merck for IP, PS Targeting advancement would spoil Xenecor and Merck revenues.

What else is Ronin not telling???

Looks like all collaborations must be disclosed and had Ronin received information from ex-Peregrine Steve Demattos ??